Role of osteopontin, a multifunctional protein, in allergy and asthma

Clinical and Experimental Allergy

Volumn 41, Issue 10, 2011, Pages 1360-1366

  Konno, S ^a   Kurokawa, M ^b   Uede, T ^c   Nishimura, M ^a   Huang, S K ^d  

^a HOKKAIDO UNIVERSITY   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

^d JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AF 808; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; MATRIX METALLOPROTEINASE; OSTEOPONTIN; OSTEOPONTIN ANTIBODY; PROTEIN ANTIBODY; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VENOM;

AIRWAY REMODELING; ALLERGIC REACTION; ALLERGY; ANGIOGENESIS; ASTHMA; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHEMOTAXIS; CHROMOSOME 4Q; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; DRUG MEGADOSE; EOSINOPHIL; EXON; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; LOW DRUG DOSE; LUNG LAVAGE; MACROPHAGE; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUALITY OF LIFE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; UPREGULATION;

ANIMALS; ASTHMA; CYTOKINES; HUMANS; HYPERSENSITIVITY; HYPERSENSITIVITY, IMMEDIATE; IMMUNOGLOBULIN E; MICE; OSTEOPONTIN;

EID: 80052962395     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03775.x     Document Type: Review

References (76)

1. Morimoto J, Kon S, Matsui Y, Uede T.Osteopontin; as a target molecule for the treatment of inflammatory diseases. Curr Drug Targets 2010; 11:494-505.
2. Ishii T, Ohshima S, Ishida Tet al. Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. Biochem Biophys Res Commun 2004; 316:809-15.
3. O'Regan AW, Hayden JM, Body Set al. Abnormal pulmonary granuloma formation in osteopontin-deficient mice. Am J Respir Crit Care Med 2001; 164:2243-7.
4. Chabas D, Baranzini SE, Mitchell Det al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science 2001; 294:1731-5.
5. O'Regan AW, Chupp GL, Lowry JA, Goetschkes M, Mulligan N, Berman JS.Osteopontin is associated with T cells in sarcoid granulomas and has T cell adhesive and cytokine-like properties in vitro. J Immunol 1999; 162:1024-31.
6. Yumoto K, Ishijima M, Rittling SRet al. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc Natl Acad Sci USA 2002; 99:4556-61.
7. Kon S, Ikesue M, Kimura Cet al. Syndecan-4 protects against osteopontin-mediated acute hepatic injury by masking functional domains of osteopontin. J Exp Med 2008; 205:25-33.
8. Yamamoto N, Sakai F, Kon Set al. Essential role of the cryptic epitope SLAYGLR within osteopontin in a murine model of rheumatoid arthritis. J Clin Invest 2003; 112:181-8.
9. Diao H, Kon S, Iwabuchi Ket al. Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 2004; 21:539-50.
10. Fan K, Dai J, Wang Het al. Treatment of collagen-induced arthritis with an anti-osteopontin monoclonal antibody through promotion of apoptosis of both murine and human activated T cells. Arthritis Rheum 2008; 58:2041-52.
11. Koguchi Y, Kawakami K, Uezu Ket al. High plasma osteopontin level and its relationship with interleukin-12-mediated type 1T helper cell response in tuberculosis. Am J Respir Crit Care Med 2003; 167:1355-9.
12. Xu G, Nie H, Li Net al. Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J Clin Invest 2005; 115:1060-7.
13. Sato T, Nakai T, Tamura Net al. Osteopontin/Eta-1 upregulated in Crohn's disease regulates the Th1 immune response. Gut 2005; 54:1254-62.
14. Comabella M, Pericot I, Goertsches Ret al. Plasma osteopontin levels in multiple sclerosis. J Neuroimmunol 2005; 158:231-9.
15. Ashkar S, Weber GF, Panoutsakopoulou Vet al. Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity. Science 2000; 287:860-4.
16. Koguchi Y, Kawakami K, Kon Set al. Penicillium marneffei causes osteopontin-mediated production of interleukin-12 by peripheral blood mononuclear cells. Infect Immun 2002; 70:1042-8.
17. Higuchi Y, Tamura Y, Uchida T, Matsuura K, Hijiya N, Yamamoto S.The roles of soluble osteopontin using osteopontin-transgenic mice in vivo: proliferation of CD4+ T lymphocytes and the enhancement of cell-mediated immune responses. Pathobiology 2004; 71:1-11.
18. Kon S, Yokosaki Y, Maeda Met al. Mapping of functional epitopes of osteopontin by monoclonal antibodies raised against defined internal sequences. J Cell Biochem 2002; 84:420-32.
19. Renkl AC, Wussler J, Ahrens Tet al. Osteopontin functionally activated dendritic cells and induces their differentiation toward a Th1-polarizing phenotype. Blood 2005; 106:946-55.
20. Konno S, Golden DBK, Schroeder J, Hamilton RG, Lichtenstein LM, Huang SK.Increased expression of osteopontin is associated with long-term bee venom immunotherapy. J Allergy Clin Immunol 2005; 115:1063-7.
21. Konno S, Golden DBK, Schroeder J, Hamilton RG, Lichtenstein LM, Huang SK.Level of osteopontin is increased after bee venom immunotherapy. J Allergy Clin Immunol 2005; 115:1317-8.
22. Li X, O'Regan AW, Berman JS.IFN-gamma induction of osteopontin expression in human monocytoid cells. J Interferon Cytokine Res 2003; 23:259-65.
23. Konno S, Eckman JA, Plunkett Bet al. Interleukin-10 and Th2 cytokines differentially regulate osteopontin expression in human monocytes and dendritic cells. J Interferon Cytokine Res 2006; 26:562-7.
24. Shinohara ML, Jansson M, Hwang ES, Werneck MB, Glimcher LH, Cantor H.T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci USA 2005; 102:17101-6.
25. Kurokawa M, Konno S, Takahashi Aet al. Regulatory role of dendritic cell-derived osteopontin in systemic allergen sensitization. Eur J Immunol 2009; 39:3323-30.
26. Xanthou G, Alissafi T, Semitekolou Met al. Osteopontin has a crucial role in allergic airway disease through regulation of dendritic cell subsets. Nat Med 2007; 13:570-8.
27. Nagasaka A, Matsue H, Matsushima Het al. Osteopontin is produced by mast cells and affects IgE-mediated degranulation and migration of mast cells. Eur J Immunol 2008; 38:489-99.
28. Takahashi A, Kurokawa M, Konno Set al. Osteopontin is involved in migration of eosinophils in asthma. Clin Exp Allergy 2009; 39:1152-9.
29. Puxeddu I, Berkman N, Ribatti Det al. Osteopontin is expressed and functional in human eosinophils. Allergy 2010; 65:168-74.
30. Kohan M, Bader R, Puxeddu I, Levi-Schaffer F, Breuer R, Berkman N.Enhanced osteopontin expression in a murine model of allergen-induced airway remodelling. Clin Exp Allergy 2007; 37:1444-54.
31. Kurokawa M, Konno S, Matsukura Set al. Effects of corticosteroids on osteopontin expression in a murine model of allergic asthma. Int Arc Allergy Immunol 2009; 149:7-13.
32. Selin DM, Kuang PP, Subramanian Met al. Interleukin-1beta induces osteopontin expression in pulmonary fibroblasts. J Cell Biochem 2006; 97:519-29.
33. Lu X, Zhang XH, Wang Het al. Expression of osteopontin in chronic rhinosinusitis with and without nasal polyps. Allergy 2009; 64:104-11.
34. Uchio E, Matsuura N, Kadonosono K, Ohno S, Uede T.Tear osteopontin levels in patients with allergic conjunctival diseases. Graefes Arch Clin Exp Ophthalmol 2002; 240:924-8.
35. Liu Y, Lu X, Yu HJet al. The expression of osteopontin and its association with Clara cell 10-kDa protein in allergic rhinitis. Clin Exp Allergy 2010; 40:1632-41.
36. Rothenberg ME, Hogan SP.The eosinophil. Annu Rev Immunol 2006; 24:147-74.
37. Kariyawasam HH, Robinson DS.The role of eosinophils in airway tissue remodeling in asthma. Curr Opin Immunol 2007; 19:681-6.
38. Humbles A, Lloyd CM, McMillian SJet al. A critical role for eosinophils in allergic airways remodeling. Science 2004; 305:1776-9.
39. Koh A, da Silva AP, Bansal AKet al. Role of osteopontin in neutrophil function. Immunology 2007; 122:466-75.
40. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L.Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 1994; 5:565-74.
41. Kitamura M, Iwabuchi K, Kitaichi Net al. Osteopontin aggravates experimental autoimmune uveoretinitis in mice. J Immunol 2007; 178:6567-72.
42. Yamamoto N, Nakashima T, Torikai Met al. Successful treatment of collagen-induced arthritis in non-human primates by chimeric anti-osteopontin antibody. Int Immunopharmacol 2007; 7:1460-70.
43. Singh M, Foster CR, Dala S, Singh K.Osteopontin: role of extracellular matrix deposition and myocardial remodeling pot-MI. J Mol Cell Cardio 2010; 48:538-43.
44. Matsui Y, Jia N, Okamoto Het al. Role of osteopontin in cardiac fibrosis and remodeling in angiotensinII-induced cardiac hypertrophy. Hypertention 2004; 43:1195-201.
45. Vetrone SA, Montecio-Rodoriguez E, Kudryashova Eet al. Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. J Clin Invest 2009; 119:1583-94.
46. Wolak T, Kim H, Ren Y, Kim J, Vaziri ND, Nicholas SB.Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 2009; 76:32-43.
47. Mori R, Shaw T, Martin P.Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. J Exp Med 2008; 205:43-51.
48. Pardo A, Gibson K, Cisneros Jet al. Up-regulation and profibrotic role of osteopontin in human idiopathic pulmonary fibrosis. PLoS Med 2005; 2:e251.
49. Kelly MM, Leigh R, Gilpin SEet al. Cell-specific gene expression in patients with unusual interstitial pneumonia. Am J Respir Crit Care Med 2006; 174:557-65.
50. Berman JS, Serlin D, Li Xet al. Altered bleomycin-induced lung fibrosis in osteopontin-deficient mice. Am J Physiol Lung Cell Mol Physiol 2004; 286:L1311-18.
51. Takahashi F, Takahashi K, Okazaki Tet al. Role of osteopontin in the pathogenesis of bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2001; 24:264-71.
52. Leali D, DellEra P, Stabile Het al. Osteopontin (Eta-1) and fibroblast growth factor-2 cross-talk in angiogenesis. J Immunol 2003; 171:1085-93.
53. Davies DE, Wicks J, Powell RM, Puddicombe SM, Holgate ST.Airway remodeling in asthma: new insights. J Allergy Clin Immunol 2003; 111:215-25.
54. Vignola AM, Kips J, Bousquet J.Tissue remodeling as a feature of persistent asthma. J Allergy Clin Immunol 2000; 105:1041-53.
55. Jeffery PK. Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med 2001; 164:S28-38.
56. Kohan M, Breuer R, Berkman N.Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma. Am J Respir Cell Mol Biol 2009; 41:290-6.
57. Simoes DC, Xanthou G, Petrochilou K, Panoutsakopolou V, Roussos C, Gratziou C.Osteopontin deficiency protects against airway remodeling and hyperresponsiveness in chronic asthma. Am J Respir Crit Care Med 2009; 179:894-902.
58. Delimpoura V, Bakakos P, Tseliou Eet al. Increased levels of osteopontin in sputum supernatant in severe refractory asthma. Thorax 2010; 65:782-6.
59. Samitas K, Zervas E, Vittorakis Set al. Osteopontin expression and relation to disease severity in human asthma. Eur Respir J 2011; 37:331-41.
60. Holgate ST, Polosa R.The mechanism, diagnosis, and management of severe asthma in adults. Lancet 2006; 368:780-93.
61. Wenzel SE, Busse WW.National Heart, Lung and Blood Institute's Severe Asthma Research Program. Severe asthma: lessons from the Severe Asthma Research Program. J Allergy Clin Immunol 2007; 119:14-21.
62. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanism in a complex, heterogenous disease. Lancet 2008; 372:1107-19.
63. Niino M, Kikuchi S, Fukazawa T, Yabe I, Tashiro K.Genetic polymorphisms of osteopontin in association with multiple sclerosis in Japanese patients. J Neuroimmunol 2003; 136:125-9.
64. Forton AC, Petri MA, Goldman D, Sullivan KE.An osteopontin (SPP1) polymorphism is associated with systemic lupus erythematosus. Hum Mutat 2002; 19:459.
65. Mochida S, Hashimoto M, Matsui Aet al. Genetic polymorphisms in promoter region of osteopontin gene may be a marker reflecting hepatitis activity in chronic hepatitis C patients. Biochem Biophys Res Commun 2004; 23:1079-85.
66. Tanino Y, Hizawa N, Konno Set al. Sequence variants of the SPP1 gene are associated with total serum IgE levels in a Japanese population. Clin Exp Allergy 2006; 36:219-25.
67. Oro AS, Guarino TJ, Driver R, Steinman L, Umetsu DT.Regulation of disease susceptibility: decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis. J Allergy Clin Immunol 1996; 97:1402-28.
68. Neukirch F, Lyon-Caen O, Clanet M, Bousquet J, Feingold J, Druet P.Asthma, nasal allergies, and multiple sclerosis. J Allergy Clin Immunol 1997; 99:270-1.
69. Shahar E, Lorber M.Allergy and SLE: common and variable. Isr J Med Sci 1997; 33:147-9.
70. Hammad H, Chieppa M, Perros F, Willart MA, Germain RN, Lambecht BN.House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells. Nat Med 2009; 15:410-6.
71. Lajoie S, Lewkowich IP, Suzuki Yet al. Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma. Nat Immunol 2010; 11:928-35.
72. Duvernelle C, Freund V, Frossard N.Transforming growth factor-beta and its role in asthma. Pulm Pharmacol Ther 2003; 16:181-96.
73. Howell JE, McAnulty RJ.TGF-beta: its role in asthma and therapeutic potential. Curr Drug Targets 2006; 7:547-65.
74. Shinohara ML, Lu L, Bu Jet al. Osteopontin expression is essential for interferon-alpha production by plasmacytoid dendritic cells. Nat Immunol 2006; 7:498-506.
75. Shinohara ML, Kim JH, Garcia VA, Cantor H.Engagement of the type I interferon receptor on dendritic cells inhibit T helper 17 cell development: role of intracellular osteopontin. Immunity 2008; 29:68-78.
76. Wakashin H, Hirose K, Maezawa Yet al. IL-23 and Th17 cells enhance Th2-cell-mediated eosinophilic airway inflammation in mice. Am J Respir Crit Care Med 2008; 178:1023-32.